Table 1.
Relationship between lncRNA SHNG1 expression and clinicopathological features of 122 HCC patients.
| Clinicopathological features (n) | lncRNA SNHG1(%) | P value | |
|---|---|---|---|
| High expression (n=70) | Low expression (n=52) | ||
| Age (yr) | |||
| >55 (66) | 40 (60.6) | 26 (39.4) | 0.434 |
| ≤55 (56) | 30 (53.6) | 26 (46.4) | |
| Gender | |||
| Male (92) | 54 (58.7) | 38 (41.3) | 0.606 |
| Female (30) | 16 (53.3) | 14 (46.7) | |
| Alcohol consumption | |||
| Low (90) | 50 (55.5) | 40 (44.5) | 0.495 |
| Excessive (32) | 20 (62.5) | 12 (37.5) | |
| Tumor size (cm) | |||
| ≤5 (82) | 38 (46.3) | 44 (53.7) | <0.001 |
| >5 (40) | 32 (80.0) | 8 (20.0) | |
| Liver cirrhosis | |||
| Yes (96) | 56 (58.3) | 40 (41.7) | 0.682 |
| No (26) | 14 (53.8) | 12 (46.2) | |
| HBsAg | |||
| Positive (98) | 56 (57.1) | 42 (42.9) | 0.916 |
| Negative (24) | 14 (58.3) | 10 (41.7) | |
| HCV Ab | |||
| Positive (22) | 12 (54.6) | 10 (45.4) | 0.767 |
| Negative (100) | 58 (58.0) | 42 (42.0) | |
| Metastasis | |||
| With (20) | 10 (50.0) | 10 (50.0) | 0.466 |
| Without (102) | 60 (58.9) | 42 (41.2) | |
| TNM stage | |||
| I–II (42) | 16 (38.1) | 26 (61.9) | 0.002 |
| III–IV (80) | 54 (67.5) | 26 (32.5) | |